News|Articles|May 2, 2004
- Pharmaceutical Technology-05-02-2004
- Volume 28
- Issue 5
aaiPharma Situation Underscores The Need for Due Diligence
Author(s)Jim Miller
Sponsors who have been lax in performing financial due diligence on their contractors have been given a wake-up call by the recent developments at aaiPharma.
Advertisement
Articles in this issue
over 21 years ago
In The Spotlight-May 2004over 21 years ago
FDA Eyes Manufacturing Innovation to Boost Drug Developmentover 21 years ago
Prepare for Bar Codingover 21 years ago
Excipient Functionalityover 21 years ago
May 2004Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars
2
AAPS PharmSci 360 2025: The Role of LC–MS in Bioanalysis
3
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
4
Why Investment Strategies Matter for Advancing Pharmaceutical Technologies
5
